A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer

This publication has 11 references indexed in Scilit:

• Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.
  Journal of Clinical Oncology, 1990
• Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience.
  Journal of Clinical Oncology, 1989
• Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer
  New England Journal of Medicine, 1988
• A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group.
  Journal of Clinical Oncology, 1988
• Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
  Journal of Clinical Oncology, 1987
• Adjuvant systemic therapy for early breast cancer
  Current Problems in Cancer, 1987
• Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
  Journal of Clinical Oncology, 1986
• Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes. A southwest oncology group study
  Cancer, 1982
• A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy
  Cancer, 1978
• Assessment of response to therapy in advanced breast cancer
  British Journal of Cancer, 1977